×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [7]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
CHEN XIN [7]
CHOU CHON KIT [2]
ZHENG YING [1]
HANMING SHEN [1]
Document Type
Journal article [7]
Book chapter [1]
Date Issued
2023 [1]
2022 [1]
2020 [1]
2018 [2]
2017 [2]
2014 [1]
More...
Language
英語English [7]
Source Publication
Cell Death and D... [1]
Cytokine [1]
FRONTIERS IN IMM... [1]
FRONTIERS IN PHA... [1]
Frontiers in Imm... [1]
Frontiers in Pha... [1]
More...
Indexed By
SCIE [5]
BKCI-S [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-8 of 8
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
TNFR2 deficiency impairs the growth of mouse colon cancer
Journal article
Li,Ping, Yang,Yang, Yang,Xinyu, Wang,Yifei, Chou,Chon Kit, Jiang,Mengmeng, Zheng,Jingbin, Chen,Fengyang, Chen,Xin*. TNFR2 deficiency impairs the growth of mouse colon cancer[J]. International Journal of Biological Sciences, 2023, 19(4), 1024-1035.
Authors:
Li,Ping
;
Yang,Yang
;
Yang,Xinyu
;
Wang,Yifei
;
Chou,Chon Kit
; et al.
Favorite
|
TC[WOS]:
8
TC[Scopus]:
7
IF:
8.2
/
8.3
|
Submit date:2023/08/03
Tumor Necrosis Factor (Tnf)
Tumor Necrosis Factor Receptor Type Ii (Tnfr2)
Colon Cancer
Cancer Immunotherapy
ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB
Journal article
Won, Minho, Park, Kyeong Ah, Kim, Sup, Ju, Eunjin, Ko, Youngbok, Yoo, Heonjong, Ro, Hyunju, Lee, Jaeseob, Oh, Junseo, Lee, Eun Gyo, Kim, Sang Yean, Nam, Suk Woo, Shen, Han Ming, Yeo, Min Kyung, Kim, Jin Man, Hur, Gang Min. ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB[J]. Cell Death and Differentiation, 2022, 29(6), 1152-1163.
Authors:
Won, Minho
;
Park, Kyeong Ah
;
Kim, Sup
;
Ju, Eunjin
;
Ko, Youngbok
; et al.
Favorite
|
TC[WOS]:
5
TC[Scopus]:
5
IF:
13.7
/
13.7
|
Submit date:2022/05/13
Tumor-necrosis-factor
Ubiquitin-binding
Tnf
Activation
Phosphorylation
Inflammation
Apoptosis
Protein
Cancer
Polyubiquitination
Preferential Expansion of CD4+Foxp3+ Regulatory T Cells (Tregs) In Vitro by Tumor Necrosis Factor
Book chapter
出自: T-Cell Receptor Signaling:Humana, New York, NY, 2020, 页码:71-78
Authors:
Chon-Kit Chou
;
Xin Chen
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
|
Submit date:2021/03/01
Cd4++++ Foxp3++++ Regulatory t Cells (Tregs)
Cfse Cell Division Assay
Flow Cytometry
Selective Expansion
Tnf Receptor 2 (Tnfr2)
Tumor Necrosis Factor (Tnf)
The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4+Foxp3+ regulatory T cells
Journal article
He T., Liu S., Chen S., Ye J., Wu X., Bian Z., Chen X.. The p38 MAPK inhibitor SB203580 abrogates tumor necrosis factor-induced proliferative expansion of mouse CD4+Foxp3+ regulatory T cells[J]. Frontiers in Immunology, 2018, 9(JUL).
Authors:
He T.
;
Liu S.
;
Chen S.
;
Ye J.
;
Wu X.
; et al.
Favorite
|
TC[WOS]:
34
TC[Scopus]:
34
|
Submit date:2018/11/06
cd4+foxp3+ Regulatory t Cells
P38 Mapk
Proliferation
Tnf Receptor Type Ii
Tumor Necrosis Factor
The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells
Journal article
He, Tianzhen, Liu, Shuoyang, Chen, Shaokui, Ye, Jingyi, Wu, Xueqiang, Bian, Zhaoxiang, Chen, Xin. The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4(+)Foxp3(+) regulatory T cells[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9.
Authors:
He, Tianzhen
;
Liu, Shuoyang
;
Chen, Shaokui
;
Ye, Jingyi
;
Wu, Xueqiang
; et al.
Favorite
|
TC[WOS]:
34
TC[Scopus]:
34
IF:
5.7
/
6.8
|
Submit date:2018/10/30
Tumor Necrosis Factor
Tnf Receptor Type Ii
P38 Mapk
Cd4(+)Foxp3(+) Regulatory t Cells
Proliferation
Drugs for autoimmune inflammatory diseases: From small molecule compounds to anti-TNF biologics
Journal article
Li,Ping, Zheng,Ying, Chen,Xin. Drugs for autoimmune inflammatory diseases: From small molecule compounds to anti-TNF biologics[J]. Frontiers in Pharmacology, 2017, 8(JUL).
Authors:
Li,Ping
;
Zheng,Ying
;
Chen,Xin
Favorite
|
TC[WOS]:
235
TC[Scopus]:
160
IF:
4.4
/
5.0
|
Submit date:2021/03/01
Anti-tnf Biologics
Autoimmune Inflammatory Diseases
Non-steroidal Anti-inflammatory Drugs (Nsaids)
Tnf Receptor
Tumor Necrosis Factor Alpha (Tnf)
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Journal article
Li, Ping, Zheng, Ying, Chen, Xin. Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics[J]. FRONTIERS IN PHARMACOLOGY, 2017, 8.
Authors:
Li, Ping
;
Zheng, Ying
;
Chen, Xin
Favorite
|
TC[WOS]:
235
TC[Scopus]:
161
IF:
4.4
/
5.0
|
Submit date:2018/10/30
Tumor Necrosis Factor Alpha (Tnf)
Autoimmune Inflammatory Diseases
Non-steroidal Anti-inflammatory Drugs (Nsaids)
Anti-tnf Biologics
Tnf Receptor
In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.
Journal article
Zhou, Q., Hu, Y., Howard, O., Oppenheim, J., Chen, X.. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4(+)Foxp3(+) regulatory T cells in vivo.[J]. Cytokine, 2014, 56-64.
Authors:
Zhou, Q.
;
Hu, Y.
;
Howard, O.
;
Oppenheim, J.
;
Chen, X.
Favorite
|
IF:
3.7
/
3.5
|
Submit date:2022/08/30
FoxP3
IL-2
KI
KO
Regulatory T cell
TNF
TNFR2
TNFR2 Fc fusion protein
TNFR2-Fc
Teffs
Th17
Tregs
effector T cells
forkhead box P3
knock in
knock out
nCD4
naïve CD4 cells
regulatory T cells
tumor necrosis factor receptor type II